IBDoc® vs The IBD Digest

IBDoc® is an in vitro diagnostic immunoassay for the quantitative determination of fecal calprotectin in human stool. It is intended as an aid to the assessment of inflammation of the intestinal mucosa for inflammatory bowel disease (e.g. Crohn’s Disease and Ulcerative Colitis) monitoring. As part of the IBDoc® calprotectin home test, the IBDoc® app allows measuring the calprotectin concentration in a stool sample using a smartphone. The app contains an easy to understand tutorial explaining the test procedure step by step from the collection of the stool sample to sample extraction and loading of the pregnancy test-like test cassette. Once the test cassette is prepared, the IBDoc® app controls the mobile device camera to take a picture of the test cassette. The optical signal of the test is analyzed with the help of a specific barcode on the test cassette. The signal is translated into a result that indicates the calprotectin concentration in the stool sample. The test information is managed on the smartphone itself and at the same time transmitted via a secure and encrypted connection to the IBDoc® Portal. The test results and connected patient information are stored securely on the IBDoc® Portal and can only be accessed by both the patient and his responsible healthcare practitioner. The IBDoc® app features include: -tutorial with schematic drawings and text explaining the test procedure step by step -A list of all test results performed by the patient -help menu with a tutorial video and support contact --------------------------------------------------- IMPORTANT NOTICE --------------------------------------------------- Please be aware that the IBDoc® app only works with an IBDoc® Account and an IBDoc® test kit. This Account has to be set up by a healthcare practitioner. Please contact your IBD doctor or IBD clinic for additional information. Please read the Instruction for Use included in the IBDoc® test kit carefully before performing the first test. The IBDoc® app has been validated for specific smartphone models to ensure accurate results, please consult the list of validated smartphones here: www.ibdoc.net/support A data connection is required. Depending on your carrier additional costs might arise. -------------------------------------------------- For IBDoc® app (BI-IBDOCAND and BI-IBDOCIOS) and IBDoc® Portal (BI-IBDOCPOR) software device: We, BÜHLMANN Laboratories AG, declare under sole responsibility that the device specified above meets the provision of the IVD Regulation (EU) 2017/746 for in vitro diagnostic medical devices, the Canadian Medical Devices Regulations SOR/98-282, and is in conformity with other relevant Union legislations, common specifications (CS) and other normative documents - CE-marked product: CE0123 - Health Canada License 98903 - In the USA, IBDoc® is available for Investigational Use Only and shall not be used for diagnostic procedures. IBDoc® and CALEX® are registered trademarks of BUHLMANN Laboratories AG in many countries.

The IBD Digest has a simple user interface which allows the user to dive right into understanding dietary decisions in order to control the inflammation in the gut. The home screen consists of information, from gut-busting foods like the best anti-inflammatory spices to eat, to the Recipe of the Month. Also, there health and wellness tips so users can take charge of their lives. The science page outlines important nutrition, offering scientific insights and clinical evidence of different foods and how they interact with the gut to improve or worsen IBD symptoms. The recipe page contains free access to a digital cookbook which has a variety of delicious IBD-friendly recipes. The IBD Digest features the Short IBD Questionnaire ("SIBDQ") which can be used to track the user’s progress during their time with the app. The questionnaire offers quantitative data on the user’s quality of life with scores that can range between 10 and 70. Legal Disclaimer: The IBD Digest app ("App") is intended solely for educational purposes and does not provide medical or treatment advice, professional diagnosis, opinions, or services. Users should not consider it as such. The information within the App should not be relied upon for medical diagnosis or as a recommendation for medical care or treatment. It is not a substitute for professional medical advice, diagnosis, or treatment. All content, including text, graphics, images, and information, is for general informational purposes only. The App does not replace expert medical attention, and users should not rely on its information as an alternative to medical advice from their doctor or other healthcare professionals. Users are strongly advised to consult their own physician or another available health professional for any diagnosis, findings, interpretation, or decisions related to prevention, treatment, and quality of life. It is crucial for users to understand that the App is not a standalone solution, and they should seek the guidance of a qualified medical professional before making any medical decisions. The information provided by the App is supplementary and should be used in conjunction with personalized advice from a healthcare provider. The scientific and medical information in this guide is provided "as is" without any representations or warranties, express or implied. Nicholas Tran, UnifIBD, or any contributors do not make representations or warranties regarding the medical information. Reliance on any information provided by the App or linked websites is at the user's own risk. Authors, contributors, and developers of this guide, along with anyone else connected to the App, will not take responsibility for the results or consequences of any attempt to use or adopt the information presented. Nicholas Tran, the App, and any other person or party that contributed to this App do not warrant that the scientific, medical, and quality of life information in this guide is complete, true, accurate, up-to-date, or non-misleading. The parties involved do not assume legal liability or responsibility for the mentioned points. By downloading and using the App, users acknowledge that they have read and understand this disclaimer, agree with its terms, and agree to be legally bound by it, effective immediately upon downloading or using the App. If users do not agree to be legally bound by this disclaimer, they may not download, access, or use the App.